Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Annals of Surgical Oncology
|
September 12, 2020
Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?
J Jaime Alberty-Oller, Sarah Weltz, Antonio Santos, et al.
Journal for Immunotherapy of Cancer
|
December 11, 2025
Systemic STING agonist therapy drives expression of interferon stimulated genes and downstream production of cytokines in dogs with solid tumors
Jennifer A Lenz, June DiBona, Matthew J Atherton, et al.
Anti-Cancer Drugs
|
October 14, 2005
Chemo-inducible gene therapy
James J Mezhir, Hank Schmidt, Bakhtiar Yamini, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
January 4, 2023
The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options
Arpit Dave, Daniel Charytonowicz, Nancy J Francoeur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2017
Patient-derived Interstitial Fluids and Predisposition to Aggressive Sporadic Breast Cancer through Collagen Remodeling and Inactivation of p53
Timothy C Kenny, Hank Schmidt, Kerin Adelson, et al.
Annals of Surgical Oncology
|
July 11, 2018
Impact of Screening Mammography on Treatment in Women Diagnosed with Breast Cancer
Soojin Ahn, Margaux Wooster, Christopher Valente, et al.
Breast Cancer Research and Treatment
|
January 4, 2021
Trends in neoadjuvant chemotherapy versus surgery-first in stage I HER2-positive breast cancer patients in the National Cancer DataBase (NCDB)
Michael Zeidman, Hank Schmidt, J Jaime Alberty-Oller, et al.
Breast Cancer Research and Treatment
|
August 3, 2020
Use of neoadjuvant versus adjuvant chemotherapy for hormone receptor-positive breast cancer: a National Cancer Database (NCDB) study
Michael Zeidman, J Jaime Alberty-Oller, Meng Ru, et al.
Oncogene
|
August 5, 2018
Mouse ER+/PIK3CA<sup>H1047R</sup> breast cancers caused by exogenous estrogen are heterogeneously dependent on estrogen and undergo BIM-dependent apoptosis with BH3 and PI3K agents
Elias E Stratikopoulos, Nicole Kiess, Matthias Szabolcs, et al.
EMBO Molecular Medicine
|
March 9, 2016
Lactation opposes pappalysin-1-driven pregnancy-associated breast cancer
Yukie Takabatake, Claus Oxvig, Chandandeep Nagi, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Annals of Surgical Oncology
|
September 12, 2020
Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?
J Jaime Alberty-Oller, Sarah Weltz, Antonio Santos, et al.
Journal for Immunotherapy of Cancer
|
December 11, 2025
Systemic STING agonist therapy drives expression of interferon stimulated genes and downstream production of cytokines in dogs with solid tumors
Jennifer A Lenz, June DiBona, Matthew J Atherton, et al.
Anti-Cancer Drugs
|
October 14, 2005
Chemo-inducible gene therapy
James J Mezhir, Hank Schmidt, Bakhtiar Yamini, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
January 4, 2023
The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options
Arpit Dave, Daniel Charytonowicz, Nancy J Francoeur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2017
Patient-derived Interstitial Fluids and Predisposition to Aggressive Sporadic Breast Cancer through Collagen Remodeling and Inactivation of p53
Timothy C Kenny, Hank Schmidt, Kerin Adelson, et al.
Annals of Surgical Oncology
|
July 11, 2018
Impact of Screening Mammography on Treatment in Women Diagnosed with Breast Cancer
Soojin Ahn, Margaux Wooster, Christopher Valente, et al.
Breast Cancer Research and Treatment
|
January 4, 2021
Trends in neoadjuvant chemotherapy versus surgery-first in stage I HER2-positive breast cancer patients in the National Cancer DataBase (NCDB)
Michael Zeidman, Hank Schmidt, J Jaime Alberty-Oller, et al.
Breast Cancer Research and Treatment
|
August 3, 2020
Use of neoadjuvant versus adjuvant chemotherapy for hormone receptor-positive breast cancer: a National Cancer Database (NCDB) study
Michael Zeidman, J Jaime Alberty-Oller, Meng Ru, et al.
Oncogene
|
August 5, 2018
Mouse ER+/PIK3CA<sup>H1047R</sup> breast cancers caused by exogenous estrogen are heterogeneously dependent on estrogen and undergo BIM-dependent apoptosis with BH3 and PI3K agents
Elias E Stratikopoulos, Nicole Kiess, Matthias Szabolcs, et al.
EMBO Molecular Medicine
|
March 9, 2016
Lactation opposes pappalysin-1-driven pregnancy-associated breast cancer
Yukie Takabatake, Claus Oxvig, Chandandeep Nagi, et al.
Page
of 4